| Date Filed | Type | Description |
| 08/25/2023 |
4
| Levine Mark S. (Chief Legal Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 12,285 shares
@ $20.3, valued at
$249.4k
Sold 1 shares
@ $20.89, valued at
$20.9 |
|
| 07/27/2023 |
4
| Levine Mark S. (Chief Legal Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 3,917 shares
@ $21.63, valued at
$84.7k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Levine Mark S. (Chief Legal Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Sold 10,156 shares
@ $18.51, valued at
$188k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Levine Mark S. (Chief Legal Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 143,000 shares
@ $0
Granted 383,000 options to buy
@ $6.72, valued at
$2.6M
|
|
| 01/28/2022 |
3
| Levine Mark S. (Chief Legal Officer) has filed a Form 3 on Immunovant, Inc. |
| 11/19/2021 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 133,486 shares
@ $8.5, valued at
$1.1M
Disposed/sold 125,000 options to buy
@ $21.74, valued at
$2.7M
Disposed/sold 33,333 options to buy
@ $22.31, valued at
$743.7k
Disposed/sold 18,000 options to buy
@ $14.75, valued at
$265.5k
Disposed/sold 15,500 options to buy
@ $15.78, valued at
$244.6k
Disposed/sold 20,000 options to buy
@ $11.41, valued at
$228.2k
|
|
| 07/20/2021 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,945 shares
@ $6.45, valued at
$25.4k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 1,023 shares
@ $10.83, valued at
$11.1k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,724 shares
@ $0 |
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 36,000 shares
@ $0
Granted 18,000 options to buy
@ $14.75, valued at
$265.5k
|
|
| 01/04/2019 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 734 shares
@ $12.36, valued at
$9.1k
|
|
| 06/22/2018 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Acquired 539 shares
@ $21.22, valued at
$11.4k
|
|
| 02/02/2018 |
4
| Levine Mark S. (General Counsel) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 8,333 shares
@ $0
Granted 33,333 options to buy
@ $22.31, valued at
$743.7k
|
|
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |